EUVIMEDEUVIMED entdecken
Crossref

Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization

Jingjing Shen, Linfu Chen, Xinying Lv, Nanhui Liu, Yu Miao, Qiang Zhang, Zhisheng Xiao, Maoyi Li, Yang Yang, Zhuang Liu, Qian Chen iD

Advanced Materials · 2024-06 · 36 (23)

DOI: 10.1002/adma.202314095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 22.02.2024. Verfasst von Jingjing Shen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Nanoparticles, Delayed-Action Preparations, Indoles. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Research Programs of China, National Natural Science Foundation of China, Collaborative Innovation Center of Suzhou Nano Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age‐related macular degeneration (AMD) disease has become a worldwide senile disease, and frequent intravitreal injection of anti‐vascular endothelial growth factor (anti‐VEGF) is the mainstream treatment in the clinic, which is associated with sight‐threatening complications. Herein, nintedanib, an inhibitor of angiogenesis, and lutein, a potent antioxidant, can co‐assemble into nanoparticles through multiple noncovalent interactions. Interestingly, the co‐assembled lutein/nintedanib nanoparticles (L/N NPs) exhibit significantly improved stability and achieve long‐term sustained release of two drugs for at least two months in mice. Interestingly, in rabbit eyeball with a more complete barrier system, the L/N NPs still successfully distribute in the retina and choroid for a month. In the laser‐induced mouse choroidal neovascularization model, the L/N NPs after a minimally invasive subconjunctival administration can successfully inhibit angiogenesis and achieve comparable and even better therapeutic results to that of standard intravitreal injection of anti‐VEGF. Therefore, the subconjunctival injection of L/N NPs with long‐term sustained drug release behavior represents a promising and innovative strategy for AMD treatment. Such minimally invasive administration together with the ability to effectively inhibit angiogenesis reduce inflammation and counteract oxidative stress and holds great potential for improving patient outcomes and quality of life in those suffering from this debilitating eye condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationNanoparticlesDelayed-Action PreparationsIndolesAnimalsRabbitsMiceAngiogenesis InhibitorsDrug LiberationHumansDrug CarriersDisease Models, Animal

Stichwörter der Autor:innen

age‐related macular degenerationantiangiogenesisanti‐inflammationco‐assembled nanoparticlessustained release

Substanzen

Delayed-Action PreparationsIndolesAngiogenesis InhibitorsnintedanibDrug Carriers

Autor:innen und Institutionen

  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, China.
  • School of Materials Science and Engineering, Tongji University, Shanghai, 201804, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P. R. China.
  • Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.

ORCID-Profile: Qian Chen

Förderung

  • National Research Programs of China
  • National Natural Science Foundation of China
  • Collaborative Innovation Center of Suzhou Nano Science and Technology
  • Suzhou Key Laboratory of Nanotechnology and Biomedicine
  • 111 Program from the Ministry of Education of China

Zitieren

APA

Shen, J., Chen, L., Lv, X., Liu, N., Miao, Y., Zhang, Q., Xiao, Z., Li, M., Yang, Y., Liu, Z., & Chen, Q. (2024). Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization. Advanced Materials, 36(23). https://doi.org/10.1002/adma.202314095

Vancouver

Shen J, Chen L, Lv X, Liu N, Miao Y, Zhang Q, et al. Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization. Advanced Materials. 2024;36(23). doi:10.1002/adma.202314095

BibTeX
@article{Shen2024,
  author = {Shen, Jingjing and Chen, Linfu and Lv, Xinying and Liu, Nanhui and Miao, Yu and Zhang, Qiang and Xiao, Zhisheng and Li, Maoyi and Yang, Yang and Liu, Zhuang and Chen, Qian},
  title = {Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {23},
  doi = {10.1002/adma.202314095}
}
Kostenlos starten →